Angioedema acquired/c1 esterase inhibitor deficiency - Altmeyers Encyclopedia

Definition
This section has been translated automatically.

Acquired angioedema at the base of an (acquired)_{C1-esterase inhibitor deficiency}. Typical are decreased values for_{C1-esterase inhibitor}, CH50, CC1q, CC1 and CC2; no heredity.

Manifestation
This section has been translated automatically.

Start of the disease in middle age.

You might also be interested in

Advertisment

Dermatology

Pseudofolliculitis barbae

Chronic hair follicle inflammation, which is characterized by curved growing hair shafts in the beard area ...

Clinical features
This section has been translated automatically.

S.u. angioedema. An important difference to allergic or pseudoallergic angioedema is the absence of (accompanying) urticaria.

Therapy
This section has been translated automatically.

In acute cases, slowly i.v. substitution of_C1-INH, repeat if necessary. Intensive medical treatment and monitoring depending on clinical appearance. Prophylactically, danazol and stanozole are used; in pregnancy and in children, tranexamic acid and epsilonaminocaproic acid (EACA) are particularly suitable. Dose and exact procedure see. Table 1.

Tables
This section has been translated automatically.

Treatment of angioedema at the base of a C1-esterase inhibitor deficiency

Acute therapy/prophylaxis	Therapy measures
Acute therapy	Analgesics for pain.
	Add_C1-INH(500-1000 units in 10 ml physiological NaCl solution), slowly i.v., the injection can be repeated depending on the clinical picture.
	If available, 500-2000 ml fresh plasma or "fresh frozen plasma".
	If indicated, intubation, tracheotomy or criotomy.
	Caution: Adrenalin, glucocorticoids and antihistamines are ineffective!
Preoperative short-term prophylaxis	Danazol about 600 mg/day, 1-10 days before the procedure.
	Alternatively: EACA approx. 6 g/day, 2-3 days before the procedure.
	Alternatively:_C1-INH approx. 500-1000 units i.v., shortly before the procedure.
Long term prophylaxis	Danazol at the beginning 600 mg/day, later reduction attempt to 200 mg/day or tranexamic acid 2-3 g/day (children: 1.5 g/day).
	Alternatively: EACA 6 g/day (children: 2 g/day).
	Alternatively:_C1-INH 500 units i.v., every 4-5 days.